May 18

Clinicians’ Perspectives on Mifepristone Regulations in Primary Care

This publication details an exploratory study of US primary care clinicians’ perspectives on the effects of mifepristone restrictions, including US Food and Drug Administration (FDA) regulations, on access to medication abortion and early pregnancy loss (EPL) management in primary care. Protocols including mifepristone are the most effective medication regimens for medication abortion and EPL management.…